The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willemsen, R. A.
Right arrow Articles by Bolhuis, R. L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willemsen, R. A.
Right arrow Articles by Bolhuis, R. L. H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2005, 174: 7853-7858.
Copyright © 2005 by The American Association of Immunologists

T Cell Retargeting with MHC Class I-Restricted Antibodies: The CD28 Costimulatory Domain Enhances Antigen-Specific Cytotoxicity and Cytokine Production1

Ralph A. Willemsen2,*, Cees Ronteltap*, Patrick Chames{dagger}, Reno Debets* and Reinder L. H. Bolhuis*

* Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus Medisch Centrum Daniel den hoed, Rotterdam, The Netherlands; and {dagger} Cellectis, Romainville, France

T cells require both primary and costimulatory signals for optimal activation. The primary Ag-specific signal is delivered by engagement of the TCR. The second Ag-independent costimulatory signal is mediated by engagement of the T cell surface costimulatory molecule CD28 with its target cell ligand B7. However, many tumor cells do not express these costimulatory molecules. We previously constructed phage display derived FAB, G8, and Hyb3, Ab-based receptors with identical specificity but distinct affinities for HLA-A1/MAGE-A1, i.e., "TCR-like" specificity. These chimeric receptors comprised the Fc{epsilon}RI-{gamma} signaling element. We analyzed whether linking the CD28 costimulation structure to it ({gamma} + CD28) could affect the levels of MHC-restricted cytolysis and/or cytokine production. Human scFv-G8POS T lymphocytes comprising the {gamma} + CD28 vs the {gamma} signaling element alone produced substantially more IL-2, TNF-{alpha}, and IFN-{gamma} in response to HLA-A1/MAGE-A1POS melanoma cells. Also a drastic increase in cytolytic capacity of scFv-G8POS T cells, equipped with {gamma} + CD28 vs the {gamma}-chain alone was observed.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. M. Kowolik, M. S. Topp, S. Gonzalez, T. Pfeiffer, S. Olivares, N. Gonzalez, D. D. Smith, S. J. Forman, M. C. Jensen, and L. J.N. Cooper
CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances In vivo Persistence and Antitumor Efficacy of Adoptively Transferred T Cells.
Cancer Res., November 15, 2006; 66(22): 10995 - 11004.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.